10. Horwitz KB, Jackson TA, Bain DL, Richer JK, Takimoto GS, Tung L 1996 Nuclear

receptor coactivators and corepressors. Mol Endocrinol 10:1167-77

11. Pike AC, Brzozowski AM, Hubbard RE 2000 A structural biologist's view of the

oestrogen receptor. J Steroid Biochem Mol Biol 74:261-8

12. Eng FC, Barsalou A, Akutsu N, et al. 1998 Different classes of coactivators recognize

distinct but overlapping binding sites on the estrogen receptor ligand binding domain. J

Biol Chem 273:28371-7

13. Hermanson O, Glass CK, Rosenfeld MG 2002 Nuclear receptor coregulators: multiple

modes of modification. Trends Endocrinol Metab 13:55-60

14. Shibata H, Spencer TE, Onate SA, et al. 1997 Role of co-activators and co-repressors in

the mechanism of steroid/thyroid receptor action. Recent Prog Horm Res 52:141-64;

discussion 164-5

15. Xu J, Li Q 2003 Review of the in vivo functions of the p160 steroid receptor coactivator

family. Mol Endocrinol 17:1681-92

16. Smith CL, Onate SA, Tsai MJ, O'Malley BW 1996 CREB binding protein acts

synergistically with steroid receptor coactivator-1 to enhance steroid receptor-dependent

transcription. Proc Natl Acad Sci U S A 93:8884-8

17. Tzukerman MT, Esty A, Santiso-Mere D, et al. 1994 Human estrogen receptor

transactivational capacity is determined by both cellular and promoter context and

mediated by two functionally distinct intramolecular regions. Mol Endocrinol 8:21-30

18. Norris JD, Fan D, Sherk A, McDonnell DP 2002 A negative coregulator for the human

ER. Mol Endocrinol 16:459-68
